Titanium mesh covered with biocompatible polypropylene film for covering and protecting bone grafts/biomaterials and process for obtaining same
US-2024398571-A1 · Dec 5, 2024 · US
US9333068B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9333068-B2 |
| Application number | US-201514601523-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jan 21, 2015 |
| Priority date | Jan 30, 2007 |
| Publication date | May 10, 2016 |
| Grant date | May 10, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A tubular tissue graft device is provided comprising a tubular tissue and a restrictive fiber matrix of a bioerodible polymer about a circumference of the tubular tissue. The matrix may be electrospun onto the tubular tissue. In one embodiment, the tubular tissue is from a vein, such as a saphenous vein, useful as an arterial graft, for example and without limitation, in a coronary artery bypass procedure. Also provided is method of preparing a tubular graft comprising depositing a fiber matrix of a bioerodible polymer about a perimeter of a tubular tissue to produce a tubular tissue graft device. A cardiac bypass method comprising bypassing a coronary artery with a tubular tissue graft device comprising a vein and a restrictive fiber matrix of a bioerodible polymer about a circumference of the vein also is provided.
Opening claim text (preview).
We claim: 1. A method of forming a tubular tissue graft device for a patient, the method comprising: inserting a mandrel inside a harvested vein segment; and electrospinning one or more synthetic fibers about a circumferential outer surface of the harvested vein segment to form a restrictive fiber matrix that is in substantial contact with the circumferential outer surface and that restricts circumferential expansion of the resulting tubular tissue graft device when grafted. 2. The method of claim 1 , wherein the harvested vein segment comprises a saphenous vein. 3. The method of claim 1 , wherein the one or more synthetic fibers comprise one or more bioerodible synthetic fibers. 4. The method of claim 3 , wherein the one or more bioerodible synthetic fibers are selected so that the restrictive fiber matrix bioerodes over a time period ranging from 12 hours to two weeks after an implantation of the tubular tissue graft device into the patient. 5. The method of claim 1 , wherein the one or more synthetic fibers comprise at least one polymer comprising urethane linkages. 6. The method of claim 1 , wherein the electrospinning comprises causing relative motion between an orifice of an electrospinning source and the mandrel while metering fluid comprising synthetic material to the orifice to deposit the one or more synthetic fibers about the circumferential outer surface of the harvested vein segment. 7. The method of claim 6 , wherein causing the relative motion comprises at least one of linear motion or spinning. 8. The method of claim 6 , wherein the electrospinning further comprises applying an electric field between the orifice and the mandrel while metering the fluid comprising the synthetic material to the orifice. 9. The method of claim 8 , wherein the electric field comprises a voltage between 3 kV and 15 kV. 10. The method of claim 1 , wherein the one or more synthetic fibers are electrospun from a fluid comprising between 1% and 15% polymer by weight. 11. The method of claim 1 , wherein the restrictive fiber matrix is formed over less than the entire outer surface of the harvested vein segment. 12. The method of claim 1 , wherein the restriction of circumferential expansion of the tubular tissue graft device provided by the restrictive fiber matrix decreases over time. 13. The method of claim 1 , wherein the restrictive fiber matrix comprises a porous mesh of the one or more synthetic fibers. 14. The method of claim 1 , wherein the electrospinning the one or more synthetic fibers comprises orienting the one or more synthetic fibers to provide anisotropy. 15. The method of claim 1 , wherein the inserting the mandrel inside the harvested vein segment comprises inserting the mandrel into and through an inner lumen of the harvested vein segment. 16. A method of performing a vascular grafting procedure in a patient, the method comprising: obtaining a tubular tissue graft device formed by the method of claim 1 ; and implanting the tubular tissue graft device into the patient as a blood vessel to perform the vascular grafting procedure. 17. The method of claim 16 , wherein the vascular grafting procedure comprises an arterial bypass grafting procedure.
Macromolecular materials · CPC title
Vascular tissue, e.g. heart valves · CPC title
for artificial blood vessels (apparatus for applying cells on a blood vessel prosthesis A61F2/062) · CPC title
Electro-spinning (non-woven fabrics produced by electro-spinning D04H1/728) · CPC title
characterised by the collecting device, e.g. drum, wheel, endless belt, plate or grid (D01D5/0046 takes precedence) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.